Weiss Multi-Strategy Advisers’s Ascendis Pharma ASND Stock Holding History
Bought
Maintained
Sold
Other funds holding ASND
BBA
Weiss Multi-Strategy Advisers's ASND Position: Q2 2022 in Review
Weiss Multi-Strategy Advisers sold out of Ascendis Pharma (ASND) in Q2 2022, closing a stake of 2,002 shares — an estimated $235K sold.
Weiss Multi-Strategy Advisers first reported a position in ASND in Q1 2015 and held it in 10 quarters. The position peaked at $2.21M in Q2 2021. 167 funds tracked by Wall St. Rank hold ASND as of Q2 2022.
- Weiss Multi-Strategy Advisers reported no remaining Ascendis Pharma position as of Q2 2022 after selling out during the quarter.
- Weiss Multi-Strategy Advisers sold 2,002 Ascendis Pharma shares in Q2 2022, an estimated $235K.
- Weiss Multi-Strategy Advisers first reported a position in Ascendis Pharma in Q1 2015 and held it in 10 quarters.
- Weiss Multi-Strategy Advisers's Ascendis Pharma position peaked at $2.21M in Q2 2021.
- 167 funds tracked by Wall St. Rank held Ascendis Pharma as of Q2 2022.
Based on Weiss Multi-Strategy Advisers's 13F filing for Q2 2022, filed 15 Aug 2022.